Immunoassays are biochemical tests that are used to quantify a
specific substance or detect an analyte in body fluid sample or in
the blood using an antibody or antigen. Immunoassays are highly
specific due to the use of purified antigens and antibodies as
reagents and it is sensitive. The common uses of immunoassay include
hormones, measurement of drugs, tumor markers, markers of cardiac
injury, and specific proteins. Immunofluorescence assays are
different type of immunoassays. The advantages of a fluorescent
detection system include higher sensitivity recognition of an
analyte, simpler assay designs, and simplified reagents. Over the
past few decades various advancements such as portability,
compactness and real time monitoring of analyzer have supported the
application of fluorescent-based immunoassay system in point-of-care.
A modern immunofluorescence assay-based analyzer uses a florescent
compound that absorbs light energy at a specific wavelength and emits
energy at a different wavelength. The difference between these light
energy is called strokes shift. Immunofluorescence assay analyzers
are extensively used in the field of clinical diagnostics, research
and development, and quality control. Lack of skilled workforce and
increasing test volume have led to the growth of immunofluorescence
analyzer market size.
Download
PDF Brochure of This Research at
https://www.coherentmarketinsights.com/insight/request-pdf/1794
Immunofluorescence Analyzer Market Dynamics
Increasing number of innovative products that are developed by
clinical diagnostic manufacturers from the results of clinical and
preclinical trials research is boosting the immunofluorescence
analyzer market growth. For instance, in 2016, AESKU group received
clearance from the Food and Drug Administration (FDA) for its new
HELIOS automated immunofluorescence system with AESKUSLIDES ANA
HEp-2-Gamma assay. HELIOS is based upon automated system for the
immunofluorescence processing with image recapturing with an
integrated software and fluorescence microscope. In a single run,
HELIOS can process and analyze patient samples. Over 300 HELIOS
systems are used worldwide in clinical research in over 40 countries.
Moreover, significance of care is now shifting towards early
detection and prevention of diseases. Therefore, private companies
are investing huge amount of capital for the development of rapid
diagnostic testing solutions and low cost imaging technologies for
point-of-care testing. For instance, in 2017, the Food and Drug
Administration provided clearance to Quidel’s point-of-care Sofia®
2 immunoassay analyzer for use with Sofia influenza A+B assay. The
next generation version, Sofia 2, is based on Quidel’s bestselling
Sofia instrumented system. Sofia 2 is integrated with wireless
connectivity and uses the florescent chemistry design with optics
system to provide automated, accurate results in 3 minutes.
Immunofluorescence Analyzer Market – Regional Insights
On the basis of region, the global immunofluorescence analyzer market
is segmented into North America, Asia Pacific, Latin America, Europe,
Middle East, and Africa. North America immunofluorescence analyzer
market accounts for the largest share in the global market, owing to
rising adoption of innovative technologies in the region. For
instance, in 2017, Siemens Healthineers launched the Atellica
Solution, an immunoassay and clinical chemistry solution that is
highly flexible, which included patented magnetic bi-directional
sample transport technology that is 10 times quicker than
conventional system. The solution can be used as scalable stand-alone
system that offers 300 customizable configurations including U-shaped
and L-shaped, and is scalable up to 10 components.
Moreover, Asia Pacific is expected to witness significant growth in
the market over the forecast period, owing to the large number of
population vulnerable to various chronic diseases and increasing
adoption of new technologies. For instance, in 2014, Sysmex
Corporation launched a compact immunochemistry testing automated
immunoassay system HISCL-800, which has high degree of sensitivity,
minute samples, fast measurement, and high operability as well as
compactness.
Browse
Report For More Information at
https://www.coherentmarketinsights.com/ongoing-insight/immunofluorescence-analyzer-market-1794
Immunofluorescence Analyzer Market – Competitive Landscape
Key players operating in the global immunofluorescence analyzer
market include Abbott Laboratories, bioMerieux, EMD Millipore,
Siemens Healthcare, Thermo Fisher Scientific, and DiaSorin S.p.A.
Major players are focused towards adopting strategies such as launch
of new innovative products to boost their product portfolio and hold
their position in the market. For instance, in 2017, Abbott received
FDA approval for its Alinity ci-series instruments. The portfolio
includes immunoassay diagnostics, clinical chemistry, blood and
plasma screening, point-of-care, hematology, and AlinIQ holistic
suite, which provides professional services with informatics and
process analysis.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and
consulting firm offering action-ready syndicated research reports,
custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
No comments:
Post a Comment